Science at Sanofi

Eosinophilic inflammation has multiple drivers^1,2

Dr. Huda Al Sahaaf discusses her experience with a 48-years-old male patient, underscoring the urgency and severe consequences of TTP when signs go unnoticed the importance of initiating aTTP treatment promptly an aTTP episode.

Prof. Robert Ritzel, Division of Endocrinology, Munich and University of Heidelberg, Germany, presents effective treatment simplification for people with T2D using fixed ration combination of iGlarLixi.

This evidence-based 3.17-minute video explores how uncontrolled atopic dermatitis creates cumulative disease burden beyond visible skin manifestations. Discover the hidden burden—psychological, social, and systemic impacts often overlooked—and the long-term implications of chronic inflammation. Learn to recognize progression patterns and the critical importance of early intervention strategies.